Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap"
International Journal of Health Policy and Management · 2024
DOI: 10.34172/ijhpm.8589 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health Policy and Management, 2024. Verfasst von Deborah Gleeson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, School of Psychology and Public Health, La Trobe University, Melbourne, VIC, Australia. Hauptthemen laut MEDLINE: Drug Industry, COVID-19, COVID-19 Vaccines, Pandemics. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Borges and colleagues rightly argue that an international treaty is needed to curtail the profit-driven behaviour of the pharmaceutical industry during pandemics. The Pandemic Agreement currently being negotiated by Member States of the World Health Organization (WHO) offers an important opportunity to equip nation states with greater leverage over industry behaviour. In this commentary, we examine the potential of current draft textual proposals for the Pandemic Agreement to redirect pharmaceutical behaviour in future pandemics. However, the future of the Agreement negotiations remains uncertain in the wake of the failure to conclude negotiations in time for the 2024 World Health Assembly (WHA). Further, there is limited consensus over proposals that could enable nation states to have greater leverage over industry behaviour. A concerted effort will need to be made to achieve a consensus text that shifts the status quo by giving nation states more power to curtail the self-interest of the pharmaceutical industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, School of Psychology and Public Health, La Trobe University, Melbourne, VIC, Australia.
- Centre for Social Impact, College of Business Government and Law, Flinders University, Adelaide, SA, Australia.
- School of Psychology and Public Health, La Trobe University, Melbourne, VIC, Australia.
- School of Regulation and Global Governance, Australian National University, Canberra, ACT, Australia.
- Centre for Law and Genetics, Faculty of Law, College of Arts, Law and Education, University of Tasmania, Hobart, TAS, Australia.
ORCID-Profile: Deborah Gleeson, James Scheibner, Brigitte Frances Tenni, Belinda Townsend, Dianne Nicol
Zitieren
APA
Gleeson, D., Scheibner, J., Tenni, B. F., Townsend, B., & Nicol, D. (2024). Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap". International Journal of Health Policy and Management. https://doi.org/10.34172/ijhpm.8589
Vancouver
Gleeson D, Scheibner J, Tenni BF, Townsend B, Nicol D. Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap". International Journal of Health Policy and Management. 2024. doi:10.34172/ijhpm.8589
BibTeX
@article{Gleeson2024,
author = {Gleeson, Deborah and Scheibner, James and Tenni, Brigitte Frances and Townsend, Belinda and Nicol, Dianne},
title = {Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap"},
journal = {International Journal of Health Policy and Management},
year = {2024},
doi = {10.34172/ijhpm.8589}
}
EUVIMED